Robins Kaplan Adds Life Sciences Attorney

New York, June 25, 2012 – Robins, Kaplan, Miller & Ciresi L.L.P. is pleased to announce that Jeffrey Hovden has joined the firm as a partner in New York in the firm’s Life Sciences and Hatch-Waxman Intellectual Property Litigation Group with a focus on generic pharmaceutical patent cases under the Hatch-Waxman Act and within the biotechnology industry. Mr. Hovden represents both generic and name-brand clients, and routinely advises clients on their intellectual property portfolios. He previously was a partner at Wilson, Sonsini, … [Read more...]